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Relationship between Metal Toxicity
to Subcellular Systems and the
Carcinogenic Response
by K. S. Squibb* and B. A. Fowler*
The effects of metals on subcellular organelle functions have been reviewed in relation to
carcinogenesis. Perturbations of the normal uptake and metabolism of carcinogens can arise
through changes in microsomal enzyme activities, membrane permeabilities, and cell turnover.
Metal effects on heme-dependent oxidative functions are well documented and are primarily
manifested by increased heme degradation rates (microsomal heme oxygenase activity),
decreased heme production (mitochondrial andcytosolic heme biosynthetic enzymes) and, in the
case ofafew metals, through nuclear effects ofmetals on the induction ofmicrosomal enzymes.
Many metals are accumulated bylysosomes, but known effects ofmetals on the function ofthese
organelles in sequestering and storing organic compounds are few. Studies ofchanges in plasma
or mitochondrial membrane permeabilities by metals have centered mainly on the susceptibility
ofmembrane ATPase activities to metal ion alteration and on the involvement ofmetals in lipid
peroxidation and free radical formation. Knowledge of the effects of metals on subcellular
organelle functions should aid in the understanding ofthe mechanisms by which metal ions may
play a role in the carcinogenic response.
In addition to recent evidence that certain trace
elements are directly carcinogenic, there is also
human epidemiological and animal experimental
evidence to suggest that metals might serve as co-
or anticarcinogens in mammalian systems (1,2).
The mechanisms by which these effects are
manifested are not well understood at the present
time; however, considerable attention is being
directed towards this question. Based on knowl-
edge ofthegeneraltoxicity ofmetals to mammalian
cells, it is possible to suggest a number of mecha-
nismswherebymetalscouldinfluencethecarcinogenic
potential of other chemicals.
The carcinogenicity ofa chemical is influenced by
a variety of factors. These include the chemical's
transport to and localization within a cell; the
metabolic activation or deactivation ofthe chemical
by the cell; and the response of the cell to the
carcinogenic reaction. It is apparent that each of
these factors involves the interaction of specific
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cellular organelle systems. Cell membranes regu-
late uptake of carcinogens; microsomal enzyme
systems are responsible for metabolism of carcino-
gens; mitochondria and lysosomes can directly or
indirectly affect detoxification and storage of car-
cinogens; and nuclear DNA polymerase enzymes
canrepairdamage donebycarcinogens. All ofthese
subcellular systems may hence influence the ulti-
mate response of the cell to the carcinogen. With
these thoughts in mind, the effects of metals on
subcellular organelles will be reviewed.
Endoplasmic Reticulum
(Microsomal Enzyme Systems
and Protein Synthesis)
Microsomes
Cellular microsomal enzyme systems are respon-
sible for the biotransformation of many hormones,
drugs, xenobiotics and environmental carcinogens.
In most instances, particularly for most drugs,
oxidation of these compounds results in a "detoxi-
181fication" of the chemical (3). A number of com-
pounds, however, including the carcinogens
benzo(a)pyrene andN-2-fluorenylacetamide, require
metabolic activation by microsomal enzymes (4-6).
For this reason, metal effects on microsomal en-
zyme activities can directly influence the carcinogenic
potential ofacompound byincreasing ordecreasing
its metabolism to a more or less carcinogenic form.
The ability of metals to affect microsomal total
P450 levels and P450 and P448-dependent enzyme
activities iswelldocumented, particularly following
acute injections of metals. Lead chloride and
methylmercuric chloride have been shown to de-
crease hepatic cytochrome P450 levels and mixed
function oxidase enzyme activities following5mg/kg
intravenous and intraperitoneal injections, respec-
tively (7). Lucier and co-workers (8) have shown
that subcutaneous injections ofmethylmercury hy-
droxide (2.5 mg/kg/day for 2 days) reduce liver
microsomal P450 and b5 levels in rats by 50%. This
reduction was accompanied by decreased aminopy-
rine demethylase activity and a decrease in smooth
endoplasmic reticulum (SER) particles. Also,
microsomalhydroxylation ofthe pesticidescarbaryl
and carbofuran was decreased following methyl-
mercury treatment (9).
Chronic exposure to 5 ppm of methylmercury
hydroxide in drinking waterhas also been shown to
produce adecrease in P450 content and aminopyrine
demethylation activity in liver microsomes after 30
days of exposure (10). Wagstaff (11), on the other
hand, observed an increase in EPN(o-ethyl-o,p-
nitrophenyl phenylphosphonothioate) detoxification
and O-demethylation activity after 15 days of
feeding mercuric acetate at levels from 0 to 2000
ppm Hg in the diet. This difference could be due to
the form of the mercury administered or to the
differences in dosage or time.
Other metals that have been shown to decrease
hepatic P450 levels following injection include chro-
mium, manganese, iron, zinc, nickel, and copper
(12). Kransy and Holbrook (13) have reported that
cadmium acetate injection increased hexobarbital
sleepingtime and decreased cytochrome P450andb5
levels and aminopyrine demethylase and aniline
hydroxylaseactivities. Thethresholddoseforinjected
cadmium is 0.84 mg Cd/kg, and the effect on P450
levels lasts at least 28 days (14). Indium chloride
injections (10-40 mg/kg) also markedly decrease
microsomalcytochrome P450levels andaminopyrine
demethylase activities in rats (15). Injections of
gold sodium thiomalate have also been shown to
inhibit ethylmorphine N-demethylase and benzo(a)
pyrene hydroxylase activities (16).
Wagstaff (17) also reported an increase in
microsomal enzyme activity and decreased hexo-
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barbital sleeping time in rats fed 1000 ppm arsenic
trioxide. Woods and Fowler (18), however, ob-
served no changes in cytochrome P450 levels or
aminopyrine demethylation activities in rats given
up to 85 ppm As as sodium arsenate in their
drinking water after 6 weeks. It is obvious that
chemical form, dosage and route of exposure to
metals can considerably influence the effects of
metals on microsomal enzymes.
The observed decrease in P450 levels in metal-
treated animals is due in large part to increases in
microsomal heme oxygenase activity, a primary
enzyme in heme degradation (19). Copper is a
potent inducer ofheme oxygenase (12). Also, injec-
tions of nickel and platinum (20) induce de novo
synthesis of heme oxygenase, along with a wide
variety of other trace elements including cobalt,
chromium, manganese, iron, zinc, cadmium, tin,
gold, mercury, lead, and selenium (13,19,21). In-
creased degradation of heme probably does not
account entirely for the decreased P450 levels,
however, and metal-induced reductions ofintracel-
lular heme production will be discussed in a later
section on mitochondrial effects ofmetal exposure.
Although most studies suggest that the effect of
metals on microsomal enzyme activities is a rather
general effect on all P450 enzymes, results of a few
studies with copper and indium indicate that the
changes in microsomal enzyme activities observed
vary dependinguponthe particularsubstrate being
studied. Yamane and co-workers (22) have re-
ported that chronic administration ofcupric acetate
inthedietsignificantlyincreased hepaticmicrosomal
azoreductase activity but depressed oxidative N-
demethylation. Moffitt and Murphy (23) also found
that elevated levels ofcupric sulfate in the drinking
waterofrats decreased aniline hydroxylase activity
by about 75% but had no affect on benzpyrene
hydroxylase activity. Similar results have been
reported by Fowler and co-workers (24) using
indium. The activities of aniline hydroxylase and
4-OH-biphenylhydroxylase weremarkedlydecreased
in rats injected with indium chloride, but the
activity ofaminopyrine demethylase was relatively
unaffected.
Data suggesting that microsomal enzyme activi-
ties are affected in humans with known exposures
to metals are limited; however, children in studies
ofchronic lead toxicity have displayed a decreased
ability to oxidatively metabolize drugs (25,26).
Also, in acute lead intoxication in adults, Meredith
and co-workers (27) and Fischbein and co-workers
(28) have reported increases in in vivo drug metab-
olism rates following chelation therapy. The in-
crease in rate is believed to be due to subsequent in-
creasedlevelsofthehepaticmicrosomalP4w enzymes.
Environmental Health PerspectivesThe major points to be derived from these
studies are that many metals may alter microsomal
enzyme activities and that the magnitude of these
effects is not uniformly distributed among the
variousmixed function oxidase activities. The prac-
tical significance of these observations rests with
theiruse as abasis forpredictingtheresponse ofan
organism to specific classes ofcarcinogens following
metal exposure and to explain the variabilities
observed in interlaboratory studies of in vitro
carcinogen test systems which use microsomal or
S9 fractions for carcinogen activation. Knowledge
of the effect of metals on microsomal enzyme
activities is hence important when usingmicrosome
activated carcinogen test systems, due to the
variation in microsomal enzyme activities in the S9
fractions that might result due to noncontrolled
changes intheexposure ofthe donorratstometals.
Protein Synthesis
Changes inprotein synthesis canreflect a specific
effect ofametalion onthe protein synthetic system
or can result from a general decrease or increase in
cell metabolism as a result of a toxic insult. In
either case, achange inprotein synthesis capability
can alter the metabolism and action ofa carcinogen
by increasing or decreasing the synthesis of
microsomal, conjugative or sulfotransferase enzyme
systems. Lead (29), arsenic(30), andmethylmercury
(31) have been shownto altertissue protein synthe-
sis rates in rats, the direction and amount depend-
ing upon the administered dose level. Rats treated
with injections ofcadmium have adecreased ability
to synthesize proteins as tested by in vitro protein
synthesizing systems (32,33) and in vivo studies
(34).
Nuclei
There are many documented effects ofmetals on
nuclear functions which may be related, either
directly or indirectly, to carcinogenesis. Most of
these have been covered extensively in separate
papers in this volume and therefore chromosomal
abnormalities induced by metals (35), and pertur-
bations of normal DNA synthesis and repair sys-
tems (36) will not be further discussed in this
section.
Not covered separately, however, are the effects
ofmetals on RNA synthesis. Injections of methyl-
mercury (31) and lead (29) increase RNA synthesis
in liver and kidney, respectively. Cadmium effects
on RNA synthesis are dependent on time and dose,
with lowlevels ofcadmiumincreasinghepatic RNA
synthesis while higher levels initially increase but
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subsequently severely decrease RNA synthesis
(33).
Nickel inhibits RNA polymerase activity and
thereby inhibits enzyme induction (37). Sunderman
and co-workers have shown that Ni(CO)4 inhibits
the induction of arylhydrocarbon hydroxylase by
phenathiazine (38), of aminopyrine demethylase
andcytochrome P450byphenobarbital(39,40) and of
tryptophan pyrrolase by cortisone (41). Beach and
Sunderman (42) have proposed that the inhibition
ofRNA polymerase activity by nickel is due to the
binding of nickel to a polymerase-chromatin com-
plex.
Beryllium also inhibits the induction of liver
enzymes. In regenerating liver, beryllium blocks
the induction ofenzymes required for DNA synthe-
sis (43). Also, beryllium inhibits the induction of
hepatic aminopyrine demethylase, tryptophan
pyrrolase and acetaniline hydroxylase by pheno-
barbital, hydrocortisone and 3-methylcholanthrene,
respectively (44). Beryllium, however, does not
significantly affect RNA or protein synthesis.
Marcotte and Witschi (45) have suggested that the
inhibition ofenzyme induction observed inresponse
to beryllium treatment may be mediated through
the binding of beryllium to nuclear proteins and
chromatin leadingto ablockage in the expression of
repressed portions of the genome.
Another way by which metals may promote a
carcinogenic response is by stimulation of cell
turnover (46,47). Concomitant exposure to car-
cinogenic agents during sensitive phases ofthe cell
replication cycle may enhance the ability ofcells to
be transformed.
Mitochondria
Mitochondria play important roles in cellular
energy production, urea production, carbohydrate
metabolism and heme biosynthesis. Although this
subcellular organelle is not generally thought to be
directly involved in mechanisms of carcinogenesis,
perturbations ofmitochondrial functions willleadto
decreased cellular energy stores (ATP) and
NAD/NADH ratios and may thereby indirectly
affect a number of cellular repair mechanisms or
the metabolism of foreign compounds. Also, the
location ofmany ofthe heme biosynthetic enzymes
in mitochondria provides a mechanism by which
metal-induceddamagetomitochondriacanadversely
affect the synthesis of cytochrome P450 enzymes
(15,19).
Mitochondrial membranes and functions are known
to be highly sensitive to metal toxicity. In vitro
studies with copper (48), cadmium (49), arsenic
(50,51), and triethyltin (52) have demonstrated that
183these metal ions are strong uncouplers ofoxidative
phosphorylation. Also, mitochondrial swelling and
increased membrane permeability is induced by in
vitro addition of metal ions such as arsenite (53),
triethyltin (52), and mercurial compounds (54).
Further studies have shown that mitochondria
are similarly sensitive to metals in vivo. Kidney
mitochondrial swelling is an early sign of the
nephrotoxicity ofchronic lead poisoning (55). Lead
decreases both mitochondrial respiration and
phosphorylation (56-58), primarily through an inhi-
bition ofthe activity ofthe NAD reductase complex
as opposed tothe succinate complex (55). Prolonged
exposure to methylmercury also produces morpho-
logical and respiratory changes in mitochondria
(59). Arsenicals have been shown to inhibit NAD-
linked mitochondrial respiration and to uncouple
oxidative-phosphorylation in vivo (60). Prolonged
oral exposure to arsenate has been found to alter
mitochondrial membrane permeability and cause
marked increases in the specific activities of the
mitochondrialmembranemarkerenzymesmonoamine
oxidase, cytochromeoxidaseandMg'2-ATPase(61).
Ultrastructural and biochemical studies of the
effect of indium chloride on mitochondria demon-
stratedmitochondrial swellinginvivo anddecreased
respiratory function in isolated mitochondria as
measured by changes in therespiratory control and
P/O ratios for NAD-linked substrates (24). Addi-
tional metals also known to alter mitochondrial
ultrastructure and function during chronic toxicity
studies include gold, copper, tin, cobalt, and cad-
mium (49,55).
The interference of metals with normal heme
metabolism is well documented and can be detected
clinically by altered porphyrin excretion patterns
that are characteristic for specific metals. Lead
exposure markedly inhibits the cytosolic enzyme
b-aminolevulinic acid (ALA) dehydratase, and two
mitochondrial heme enzymes, coproporphyrinogen
oxidase and ferrochelatase, while increasing the
activities of mitochondrial ALA synthetase (62).
These changes in enzyme activities account for the
marked increase in circulating and urinary ALA
and coproporphyrin during lead exposure. Methyl-
mercury exposure in adult rats has been shown to
produce a2.5-fold increase in renalALA synthetase
and a decrease in ferrochelatase leading to an
approximately 21-fold increase in urinary excretion
ofcoproporphyrin (63). Arsenic exposure decreases
ferrochelatase and ALA synthetase and increases
uroporphyrinogen I synthetase activity giving rise
to an increase in urinary uroporphyrin (18). Injec-
tions of gold sodium thiomalate decrease hepatic
and renal ALA dehydratase and ferrochelatase
activities (16). Indium chloride injections depress
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the activity of ALA synthetase (15). These alter-
ations in heme synthesis play an important role, in
concert with changes in heme oxygenase activity,
in regulating the levels of microsomal P450 in cells
(19).
Lysosomes
Lysosomes are known to accumulate and seques-
terforeign organiccompounds, includingsuchchem-
icals as drugs and dyes (64). Compromise of this
system by metal ions could perturb normal carcino-
gen detoxification mechanisms. Many metals, in-
cludingmercury (65-67), lead (68), copper (69), gold
(70), and zinc (71), are known to accumulate in
lysosomes during prolonged exposures. Despite
this, data on the effects of metals on lysosomal
enzyme activities are scanty. Methylmercury expo-
sure has been shown to decrease lysosomal ,B-
glucuronidase and increase lysosomal acid phospha-
tase activities (72). Also, Mego and Cain (73) have
reported that intraperitoneal injections of LD50
doses ofcadmium inhibit heterolysosome formation
and function with respect to protein degradation.
Cellular Membranes
This subcellular organelle system is one of the
least well studied in trace metal toxicity experi-
ments, despite its important role in mediating the
transport of materials into and out of the cell. A
change in cell permeability could directly affect the
uptake ofcarcinogens bythecellandthereby either
decrease or increase the functional dose of the
carcinogen to the cell.
Metal-induced changes in membrane permeabil-
ity have been demonstrated following exposure to
lead and mercury. Early studies with lead have
shown that decreased osmotic fragility and in-
creased mechanical fragility of erythrocytes are
associated with lead poisoning in humans (74). Also
Weed and co-workers (75) have demonstrated that
mercury ions (Hg+2) added in vitro can readily
change the permeability of cell membranes.
Thebiochemicalmechanismsresponsible forthese
alterations are not well known at thistime. Howev-
er, studies of the sensitivity of membrane Na/K
ATPase activities to metals have received consid-
erable attention due to the general inhibition ofthis
enzymeby sulfhydryl-binding agents. Na/KATPase
plays arole in the control ofsolute transport across
membranes by supplying energy for transport
through the maintenance of a Na/K ionic gradient
across the membrane. In vitro, cadmium (76),
arsenite (77), and beryllium (78) will inhibit Na/K
ATPase. Similarly, lead has been shown to inhibit
Environmental Health Perspectivesmembrane ATPases in in vitro studies (79) and in
guinea pig kidney homogenates from lead-poisoned
animals (80) and in red blood cell preparations from
industrially exposed workers (81). Various mercu-
rial compounds have been shown to inhibit red
blood cell membrane Na/K ATPase activity by in
vitro addition ofthe metal (82), and organic mercu-
rial diuretics inhibit kidney ATPase both in vitro
and in vivo in rats pretreated with the mercurial
drugs, meralluride and mercaptomerine (83).
Nondiuretic mercurials, p-chloromercuribenzoate
and p-chloromercuriphenyl sulfonate, are more ac-
tive inhibitors in vitro than the diuretics but have
no effect in vivo. This occurs despite the fact that
both types ofcompounds bind equally well to renal
membrane fractions (84). Nickel chloride also inhib-
its ATPase activity in capillary walls following
injection of the metal (85,86).
A second mechanism by which toxic trace metals
might influence membrane permeability is through
the perturbation ofessential trace element metabo-
lism. Recent evidence has suggested that trace
elements such as zinc (87) and selenium in concert
with vitamin E (88) mightplay arole inmaintaining
membrane integrity through the stabilization of
membrane structure and controloflipidperoxidation.
Cadmium exposure has been shown to perturb
normal zinc metabolism (89,90) while selenium
metabolism is altered by mercury exposure (91).
Another area ofmetal research that is ofinterest
in relation to membrane permeability changes and
the carcinogenicity of metals is the involvement of
metal ions in free radical reactions. The biomethyl-
ation of a number of metals is thought to involve
free radical intermediates (92). Also, and more
importantly, numerous metals are capable of serv-
ing as oxidative catalysts. The decomposition of
hydrogen peroxide with resultant formation ofthe
hydroxyl radical (93) and the formation of the
superoxide radical ion (94) are two important metal-
catalyzed reactions that can serve to produce chain-
initiating free radicals. Lipid peroxidation induced
by these free radicals can be further propagated by
metal ions via an acceleration ofthe breakdown of
secondarily formed peroxides and other lipid moie-
ties (95). Therefore, it is possible that metal-
induced lipid peroxidation can lead to changes in
membrane structure andpermeability, which canin
turn affect the transport and therefore the
carcinogenicity of organic carcinogens. In vivo
evidence for metal-induced lipid peroxidation oc-
curs in the form of chromolipid granules that
appear in various organs of animals treated with
iron, copper, lead, bismuth, mercury, silver, and
gold (95). Iron, in particular, has been shown to
accelerate lipid peroxidation in tissue hemogenates
and organelle suspensions (95).
Other consequences oflipid peroxidation and free
radical production are also possible and might be
important in terms of metal carcinogenicity.
Malonaldehyde, a by-product of lipid peroxidation
(93,16), has been shown to react with DNA both in
vivo and in vitro (97) and may be both mutagenic
(98) and carcinogenic (99). Also, more directly,
Stich and co-workers have recently suggested that
free radicals might be direct carcinogens (100,101).
These workers have suggested that DNA damage
induced by hydrazine compounds in cultured cells is
mediated by the production of free radicals from a
hydrogen peroxide intermediate. Inlightofthe fact
that free radicals have been implicated in the
carcinogenicity of ionizing radiation and chemical
carcinogens (102), it is possible that free radical
production by metal ions might well play a role in
metal carcinogenesis.
Summary
Due to the many factors that can influence the
carcinogenicity ofachemical, a discussion ofmetals
and carcinogenesis is not complete without a dis-
cussion of the effects of metals on subcellular
organelle functions. Changes in the uptake and
metabolism of compounds could considerably alter
the final carcinogenic response ofa cell. Metal ions
have been shown to alter normal microsomal en-
zyme activities, by mechanisms involving changes
in the synthesis and degradation of the enzymes.
These effects can occur through nuclear effects
(i.e., inhibition of DNA/RNA synthesis causing an
inhibition of enzyme induction) or through the
inhibition of heme production via affects on mito-
chondrial heme biosynthesis or mitochondrial en-
ergy production. Changes in membrane permeabil-
ity by metals could potentially affect the transport
of carcinogens into cells, thereby changing their
functional dose. In all areas of metal toxicity to
subcellular organelle systems, further research is
needed to provide a better understanding of the
mechanisms by which metal ions might play co- or
anticarcinogenic roles. Knowledge of the specific
effects ofmetals on subcellular systems can be well
used in the formulation of experiments looking at
interactions between metals and carcinogens, par-
ticularly those involving microsomal in vitro test
systems and whole animal metal-carcinogen inter-
action studies.
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